Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frances L. Johnson is active.

Publication


Featured researches published by Frances L. Johnson.


Nature Medicine | 2001

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis.

Christopher Heeschen; James J. Jang; Michael Weis; Anjali Pathak; Shuichiro Kaji; Robert S. Hu; Philip S. Tsao; Frances L. Johnson; John P. Cooke

We provide anatomic and functional evidence that nicotine induces angiogenesis. We also show that nicotine accelerates the growth of tumor and atheroma in association with increased neovascularization. Nicotine increased endothelial-cell growth and tube formation in vitro, and accelerated fibrovascular growth in vivo. In a mouse model of hind-limb ischemia, nicotine increased capillary and collateral growth, and enhanced tissue perfusion. In mouse models of lung cancer and atherosclerosis, we found that nicotine enhanced lesion growth in association with an increase in lesion vascularity. These effects of nicotine were mediated through nicotinic acetylcholine receptors at nicotine concentrations that are pathophysiologically relevant. The endothelial production of nitric oxide, prostacyclin and vascular endothelial growth factor might have a role in these effects.


Circulation | 2003

Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction

Mary M. Chen; Euan A. Ashley; David Deng; Anya Tsalenko; Alicia Deng; Raymond Tabibiazar; Amir Ben-Dor; Brett E. Fenster; Eugene Yang; Jennifer Y. King; Michael B. Fowler; Robert C. Robbins; Frances L. Johnson; Laurakay Bruhn; Theresa McDonagh; Henry J. Dargie; Zohar Yakhini; Philip S. Tsao; Thomas Quertermous

Background—Apelin is among the most potent stimulators of cardiac contractility known. However, no physiological or pathological role for apelin–angiotensin receptor-like 1 (APJ) signaling has ever been described. Methods and Results—We performed transcriptional profiling using a spotted cDNA microarray with 12 814 unique clones on paired samples of left ventricle obtained before and after placement of a left ventricular assist device in 11 patients. The significance analysis of microarrays and a novel rank consistency score designed to exploit the paired structure of the data confirmed that natriuretic peptides were among the most significantly downregulated genes after offloading. The most significantly upregulated gene was the G-protein–coupled receptor APJ, the specific receptor for apelin. We demonstrate here using immunoassay and immunohistochemical techniques that apelin is localized primarily in the endothelium of the coronary arteries and is found at a higher concentration in cardiac tissue after mechanical offloading. These findings imply an important paracrine signaling pathway in the heart. We additionally extend the clinical significance of this work by reporting for the first time circulating human apelin levels and demonstrating increases in the plasma level of apelin in patients with left ventricular dysfunction. Conclusions—The apelin-APJ signaling pathway emerges as an important novel mediator of cardiovascular control.


Journal of Heart and Lung Transplantation | 2003

Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review.

Fred A. Lopez; Frances L. Johnson; Denise M. Novosad; Blaine L. Beaman; Mark Holodniy

Nocardia transvalensis is a rarely reported cause of clinically significant disease, and, to our knowledge, has not been reported previously as a cause of infection in the cardiac transplant population. We report a case of N transvalensis new taxon-2 pulmonary infection that disseminated to the brain and skin in a cardiac transplant recipient despite adequate sulfonamide serum levels. Subsequent isolates were resistant to sulfonamides, and molecular ribotyping of the primary and subsequent isolates confirmed that these were the same N transvalensis new taxon-2 strain. The taxonomic and diagnostic considerations, as well as the clinical significance of anti-microbial-resistant nocardia, are reviewed and discussed herein.


Circulation | 2014

Microtubule-Mediated Defects in Junctophilin-2 Trafficking Contribute to Myocyte Transverse-Tubule Remodeling and Ca2+ Handling Dysfunction in Heart FailureCLINICAL PERSPECTIVE

Caimei Zhang; Biyi Chen; Ang Guo; Yanqi Zhu; Jordan D. Miller; Shan Gao; Can Yuan; William Kutschke; Kathy Zimmerman; Robert M. Weiss; Xander H.T. Wehrens; Jiang Hong; Frances L. Johnson; Luis F. Santana; Mark E. Anderson; Long-Sheng Song

Background— Cardiac dysfunction in failing hearts of human patients and animal models is associated with both microtubule densification and transverse-tubule (T-tubule) remodeling. Our objective was to investigate whether microtubule densification contributes to T-tubule remodeling and excitation–contraction coupling dysfunction in heart disease. Methods and Results— In a mouse model of pressure overload–induced cardiomyopathy by transaortic banding, colchicine, a microtubule depolymerizer, significantly ameliorated T-tubule remodeling and cardiac dysfunction. In cultured cardiomyocytes, microtubule depolymerization with nocodazole or colchicine profoundly attenuated T-tubule impairment, whereas microtubule polymerization/stabilization with taxol accelerated T-tubule remodeling. In situ immunofluorescence of heart tissue sections demonstrated significant disorganization of junctophilin-2 (JP2), a protein that bridges the T-tubule and sarcoplasmic reticulum membranes, in transaortic banded hearts as well as in human failing hearts, whereas colchicine injection significantly preserved the distribution of JP2 in transaortic banded hearts. In isolated mouse cardiomyocytes, prolonged culture or treatment with taxol resulted in pronounced redistribution of JP2 from T-tubules to the peripheral plasma membrane, without changing total JP2 expression. Nocodazole treatment antagonized JP2 redistribution. Moreover, overexpression of a dominant-negative mutant of kinesin 1, a microtubule motor protein responsible for anterograde trafficking of proteins, protected against JP2 redistribution and T-tubule remodeling in culture. Finally, nocodazole treatment improved Ca2+ handling in cultured myocytes by increasing the amplitude of Ca2+ transients and reducing the frequency of Ca2+ sparks. Conclusion— Our data identify a mechanistic link between microtubule densification and T-tubule remodeling and reveal microtubule-mediated JP2 redistribution as a novel mechanism for T-tubule disruption, loss of excitation–contraction coupling, and heart failure.


Archive | 2002

Molecular Biology of Vascular Remodeling

Philip S. Tsao; Jay Wohlgemuth; Mehrdad Rezaee; Frances L. Johnson; Stéphane C. Boutet; Bahaa M. Fadel; Thomas Quertermous

The earliest form of vascular remodeling occurs during embryonic development, during vascular formation. In this process endothelial cells arise and form a dense plexus throughout the mesoderm. This plexus then remodels to form a recognizable branching vascular pattern. This remodeling has been considered to be primarily an endothelial cell event. It is now increasingly clear that this earliest form of remodeling actually represents a complex coordinated development process involving endothelial cells and smooth muscle cells. Recent gene-targeting experiments have begun to dissect the signaling pathways that mediate various aspects of this complex process, which appears to be regulated by secreted factors and physical forces. Subsequently, there is extensive remodeling as the primitive vascular pattern reorganizes to reflect the definitive circulation found in higher vertebrates. And finally, there is continuous remodeling in embryogenesis and during postnatal development as the organism increases in size.


Science | 2001

Physiological Migration of Hematopoietic Stem and Progenitor Cells

Douglas E. Wright; Amy J. Wagers; Anjali Pathak Gulati; Frances L. Johnson; Irving L. Weissman


American Journal of Physiology-cell Physiology | 2001

NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases

Troy Stevens; Robert D. Rosenberg; William C. Aird; Thomas Quertermous; Frances L. Johnson; Joe G. N. Garcia; Robert P. Hebbel; Rubin M. Tuder; Susan Garfinkel


Molecular Therapy | 2001

Combination Angiostatin and Endostatin Gene Transfer Induces Synergistic Antiangiogenic Activity in Vitro and Antitumor Efficacy in Leukemia and Solid Tumors in Mice

Frank A. Scappaticci; Richard H. Smith; Anjali Pathak; Derrick J. Schloss; Bert L. Lum; Yihai Cao; Frances L. Johnson; Edgar G. Engleman; Garry P. Nolan


Microvascular Research | 2002

The Embryonic Angiogenic Factor Del1 Accelerates Tumor Growth by Enhancing Vascular Formation

Yoshikazu Aoka; Frances L. Johnson; Kalyani Penta; Ken-ichi Hirata; Chiaki Hidai; Randall Schatzman; Judith A. Varner; Thomas Quertermous


Archive | 2001

Leukocyte expression profiling

Jay Wohlgemuth; Kirk Fry; George R. Matcuk; Peter Altman; James Prentice; Julie Phillips; Ngoc Ly; Robert Woodward; Thomas Quertermous; Frances L. Johnson

Collaboration


Dive into the Frances L. Johnson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John P. Cooke

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christopher Heeschen

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

George R. Matcuk

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Garrick C. Stewart

Brigham and Women's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge